D745 clinical trials
How each study uses D745 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- D745
- 1
Studies by the year they started
4 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Lobeglitazone (1) · CKD-370 (1)
Studies
Open first, then newest update. How each study uses D745 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 DiabetesCompletedPhase 3Chong Kun Dang PharmaceuticalNCT05566028Written as D745 formulation I
- A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150CompletedPhase 1Chong Kun Dang PharmaceuticalNCT05928637Written as D745, D759, D150
- A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150CompletedPhase 1Chong Kun Dang PharmaceuticalNCT04334213Written as D745, D150
- Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy AdultsStatus unknownPhase 1Chong Kun Dang PharmaceuticalNCT03849495Written as D745